Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
imatinib (gleevec) (1 trial)
anastrozole (arimidex) (1 trial)
cladribine (leustatin) (1 trial)
fulvestrant (faslodex) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
Breast Neoplasms (Phase 3)
Mastocytosis (Phase 4)
Mastocytosis, Systemic (Phase 4)
Trials (3 total)
Trial APIs (5 total)